Armata Pharmaceuticals Announces Presentation at the 6th Annual Bacteriophage Therapy Summit [Yahoo! Finance]
Armata Pharmaceuticals, Inc. (ARMP)
Company Research
Source: Yahoo! Finance
focused on pathogen-specific bacteriophage therapeutics for antibiotic-resistant and difficult-to-treat bacterial infections, today announced that Mina Pastagia , M.D., Chief Medical Officer, will deliver a presentation at the 6th Annual Bacteriophage Therapy Summit, which is being held February 27-29 in Boston Details of the presentation are as follows: Title: Armata Clinical Trials Overview of Bacteriophage Administration for Difficult-To-Treat Infections Day: Wednesday, February 28 Time: 12:00 p.m. ET Location: Wyndham Boston Beacon Hill Dr. Pastagia's presentation will cover a range of topics related to Armata's ongoing development programs, including: The advantages of a multi-phage cocktail approach in subjects with chronic Pseudomonal respiratory infections; The similarities of phage distribution and phage kinetics between cystic fibrosis and non-cystic fibrosis bronchiectasis (NCFB) subjects who were administered Armata's nebulized phage candidate, AP-PA02; T
Show less
Read more
Impact Snapshot
Event Time:
ARMP
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ARMP alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ARMP alerts
High impacting Armata Pharmaceuticals, Inc. news events
Weekly update
A roundup of the hottest topics
ARMP
News
- Armata Pharmaceuticals Announces Fourth Quarter and Full-Year 2023 Results and Provides Corporate Update [Yahoo! Finance]Yahoo! Finance
- Armata Pharmaceuticals Announces Fourth Quarter and Full-Year 2023 Results and Provides Corporate UpdatePR Newswire
- Armata Pharmaceuticals Announces $35 Million Secured Credit Agreement with Innoviva [Yahoo! Finance]Yahoo! Finance
- Armata Pharmaceuticals Announces $35 Million Secured Credit Agreement with InnovivaPR Newswire
- Armata Pharmaceuticals Announces Presentation at the 6th Annual Bacteriophage Therapy SummitPR Newswire
ARMP
Earnings
- 11/14/23 - Miss
ARMP
Sec Filings
- 4/29/24 - Form ARS
- 4/29/24 - Form DEF
- 3/22/24 - Form 8-K
- ARMP's page on the SEC website